HUMAN CYTOMEGALOVIRUS IMMUNOGLOBULIN (CMVIG) (Cytotect CP Biotest®)

Clinical Indication

Clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy

Comments

Not yet reviewed

Date of classification

February 2020

Review date

February 2020

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.